Circulating tumor DNA (ctDNA) as a prognostic marker for recurrence in resected pancreas cancer.

被引:0
|
作者
Wang, Judy Sing-Zan
Sausen, Mark
Parpart-Li, Sonya
Murphy, Derek M.
Velculescu, Victor E.
Wood, Laura D.
Solt-Linville, Sara
Sugar, Elizabeth
Bartlett, Bjarne
Blair, Cherie
Dauses, Tianna
Jaffee, Elizabeth M.
Hruban, Ralph H.
Laheru, Dan
Diaz, Luis A.
机构
[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[2] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA
[3] Personal Genome Diagnost Inc, Baltimore, MD USA
[4] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[5] Johns Hopkins Univ Sch Med, Dept Pathol, Baltimore, MD USA
[6] Johns Hopkins Sch Publ Hlth Dept Biostat, Baltimore, MD USA
[7] Johns Hopkins Univ Sch Med, Baltimore, MD USA
[8] Sidney Kimmel Comp Canc Ctr, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
11025
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Circulating tumor DNA and recurrence risk in stage II-III gastric cancer.
    Yuan, Shu-Qiang
    Huang, You-Sheng
    Nie, Run-Cong
    Chen, Yingbo
    Wang, Si-Yu
    Sun, Xiaowei
    Li, Yuanfang
    Liu, Ze-Kun
    Chen, Yan-Xing
    Yao, Yi-Chen
    Xu, Yu
    Qiu, Haibo
    Liang, Yao
    Wang, Wei
    Zhou, Zhiwei
    Xu, Rui-Hua
    Wang, Feng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] The potential of circulating cell-free tumor DNA as a diagnostic marker of ovarian cancer.
    Yamamoto, Misa
    Sawada, Kenjiro
    Shimizu, Aasa
    Kinose, Yasuto
    Kodama, Michiko
    Hashimoto, Kae
    Kimura, Tadashi
    [J]. CANCER SCIENCE, 2021, 112 : 875 - 875
  • [33] Numerical aberrations of chromosome 9 in bladder cancer. A possible prognostic marker for early tumor recurrence
    Tsukamoto, M
    Matsuyama, H
    Oba, K
    Yoshihiro, S
    Takahashi, M
    Naito, K
    [J]. CANCER GENETICS AND CYTOGENETICS, 2002, 134 (01) : 41 - 45
  • [34] The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA
    Liu, Binliang
    Hu, Zheyu
    Ran, Jialu
    Xie, Ning
    Tian, Can
    Tang, Yu
    Ouyang, Quchang
    [J]. BREAST, 2022, 65 : 116 - 123
  • [35] Prognostic utility of preoperative and postoperative circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
    Alqahtani, Ali
    Alloghbi, Abdurahman
    Yin, Chao
    Mukherji, Reetu
    Weinberg, Benjamin Adam
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [36] Circulating cell free tumor DNA detection as a prognostic tool in advanced pancreatic cancer.
    Botrus, Gehan
    Uson, Pedro Luiz Serrano, Jr.
    Raman, Puneet
    Kaufman, Adrienne
    Kosiorek, Heidi E.
    Sonbol, Mohamad Bassam
    Borad, Mitesh J.
    Ahn, Daniel H.
    Chang, Isabela
    Drusbosky, Leylah
    Starr, Jason S.
    Mody, Kabir
    Bekaii-Saab, Tanios S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] The landscape of genomic alterations detected in serial circulating tumor DNA (ctDNA) in clinical progressive metastatic breast cancer.
    Jacob, Saya
    Davis, Andrew A.
    Gerratana, Lorenzo
    Shah, Ami N.
    Katam, Neelima
    Zhang, Qiang
    Wehbe, Firas
    Flaum, Lisa E.
    Siziopikou, Kalliopi P.
    Platanias, Leonidas C.
    Gradishar, William John
    Behdad, Amir
    Cristofanilli, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Circulating tumor DNA as a prognostic marker in colorectal cancer: Preliminary results of a prospective trial
    Laurent-Puig, Pierre
    Bouche, Olivier
    Niarra, Ralph
    Aucouturier, Pascaline
    Benhaim, Leonor
    Landi, Bruno
    Berger, Anne
    Lecomte, Thierry
    Normand, Corinne
    Le Corre, Delphine
    Didelot, Audrey
    Mallet, Karine
    Toralla, Karla Perez
    Hor, Thevy
    El Harrak, Zakaria
    Chatellier, Gilles
    Hutchison, Brian
    Link, Darren
    Taly, Valerie
    [J]. CANCER RESEARCH, 2015, 75
  • [39] Circulating Tumor DNA Is an Accurate Diagnostic Tool and Strong Prognostic Marker in Pancreatic Cancer
    Sellahewa, Rav
    Moghaddam, Samar Masoumi
    Lundy, Joanne
    Jenkins, Brendan J.
    Croagh, Daniel
    [J]. PANCREAS, 2023, 52 (03) : e188 - e195
  • [40] Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
    Chan, Hiu Ting
    Nagayama, Satoshi
    Otaki, Masumi
    Chin, Yoon Ming
    Fukunaga, Yosuke
    Ueno, Masashi
    Nakamura, Yusuke
    Low, Siew-Kee
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12